Description
Afatinib 30 mg is a targeted oral medication used to treat non-small cell lung cancer (NSCLC), specifically in patients with epidermal growth factor receptor (EGFR) mutations. As an advanced tyrosine kinase inhibitor (TKI), Afatinib works by blocking abnormal protein signals that stimulate cancer cell growth and spread, effectively slowing or stopping disease progression.
Key Features and Benefits
-
Targeted Therapy – Afatinib 30 mg focuses on EGFR mutations, delivering a more precise approach compared to traditional chemotherapy.
-
Improved Disease Control – Studies show enhanced progression-free survival rates and better tumor reduction outcomes.
-
Convenient Oral Dosage – Taken once daily, this medication offers a simple and manageable treatment option for patients.
Medical Usage
Afatinib 30 mg is primarily prescribed for patients with metastatic NSCLC or those who have experienced progression following other EGFR-targeted therapies. It is recommended to take the medication on an empty stomach, either one hour before or two hours after meals, as directed by a healthcare provider.
Possible Side Effects
Common side effects include diarrhea, skin rash, fatigue, mouth sores, and nausea. Severe or persistent reactions should be reported to a medical professional immediately.
Why Choose QuickRxHub?
At QuickRxHub, we provide genuine Afatinib 30 mg sourced from trusted manufacturers. Our service ensures quality assurance, competitive pricing, and secure, discreet delivery directly to your doorstep.